TY - JOUR
T1 - A comparison of cerebral blood flow and glucose metabolism in olivopontocerebellar atrophy using PET
AU - Gilman, Sid
AU - St. Laurent, R. T.
AU - Koeppe, R. A.
AU - Junck, L.
AU - Kluin, K. J.
AU - Lohman, M.
PY - 1995/7
Y1 - 1995/7
N2 - In sporadic cases of olivopontocerebellar atrophy (OPCA), to determine whether local cerebral blood flow (ICBF) is reduced, whether lCBF is coupled to local cerebral metabolic rate for glucose (lCMRglc), and whether lCBF measurements are potentially useful in diagnosing OPCA. Design Positron emission tomography was used with [15 O]H 2 O to measure lCBF and with [18 F]fluorodeoxyglucose to measure lCMRglc in 17 patients with OPCA and 21 normal control subjects. Results In OPCA patients, lCBF was significantly decreased in the cerebellum, but not in the cerebral cortex, basal ganglia, thalamus, or brainstem. In the same patients, lCMRglc was significantly decreased in the cerebellum and brainstem, where the largest changes were observed, and also in the cerebral cortex, basal ganglia, and thalamus. The ratio of lCBF to lCMRglc, an indicator of the coupling of blood flow to metabolism, was similar in OPCA patients and normal subjects for all regions except the brainstem, where the ratio was marginally decreased in OPCA patients. Using logistic discriminant analysis to assess the ability of lCBF and lCMRglc to differentiate OPCA patients from normal subjects, we found the cross-validated sensitivity of absolute lCMRglc as a predictor of OPCA was 8% with a corresponding specificity of 71% the sensitivity of absolute lCBF was 71% and the specificity 76% Conclusions In sporadic cases of OPCA, lCBF is reduced in the cerebellum, CBF remains coupled to lCMRglc, and the lCBF pattern is a useful predictor of the diagnosis.
AB - In sporadic cases of olivopontocerebellar atrophy (OPCA), to determine whether local cerebral blood flow (ICBF) is reduced, whether lCBF is coupled to local cerebral metabolic rate for glucose (lCMRglc), and whether lCBF measurements are potentially useful in diagnosing OPCA. Design Positron emission tomography was used with [15 O]H 2 O to measure lCBF and with [18 F]fluorodeoxyglucose to measure lCMRglc in 17 patients with OPCA and 21 normal control subjects. Results In OPCA patients, lCBF was significantly decreased in the cerebellum, but not in the cerebral cortex, basal ganglia, thalamus, or brainstem. In the same patients, lCMRglc was significantly decreased in the cerebellum and brainstem, where the largest changes were observed, and also in the cerebral cortex, basal ganglia, and thalamus. The ratio of lCBF to lCMRglc, an indicator of the coupling of blood flow to metabolism, was similar in OPCA patients and normal subjects for all regions except the brainstem, where the ratio was marginally decreased in OPCA patients. Using logistic discriminant analysis to assess the ability of lCBF and lCMRglc to differentiate OPCA patients from normal subjects, we found the cross-validated sensitivity of absolute lCMRglc as a predictor of OPCA was 8% with a corresponding specificity of 71% the sensitivity of absolute lCBF was 71% and the specificity 76% Conclusions In sporadic cases of OPCA, lCBF is reduced in the cerebellum, CBF remains coupled to lCMRglc, and the lCBF pattern is a useful predictor of the diagnosis.
UR - http://www.scopus.com/inward/record.url?scp=0029160615&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029160615&partnerID=8YFLogxK
U2 - 10.1212/WNL.45.7.1345
DO - 10.1212/WNL.45.7.1345
M3 - Article
C2 - 7617196
AN - SCOPUS:0029160615
SN - 0028-3878
VL - 45
SP - 1345
EP - 1352
JO - Neurology
JF - Neurology
IS - 7
ER -